<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0139">‘Next-generation’ bNAbs, which have been engineered to improve their therapeutic properties, i.e. with enhanced breadth, effector function and extended half-life were also discussed. Several clinical trials involving bNAbs in various combination strategies are currently in progress and many more are planned that will provide valuable information for future cure strategies.</p>
